US SB935 | 2023-2024 | 118th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: Introduced on March 22 2023 - 25% progression, died in committee
Action: 2023-03-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 22 2023 - 25% progression, died in committee
Action: 2023-03-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require reporting regarding certain drug price increases, and for other purposes.
Title
Fair Accountability and Innovative Research Drug Pricing Act of 2023
Sponsors
| Sen. Tammy Baldwin [D-WI] | Sen. Mike Braun [R-IN] | Sen. Tina Smith [D-MN] | Sen. Martin Heinrich [D-NM] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-03-22 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/935/all-info |
| Text | https://www.congress.gov/118/bills/s935/BILLS-118s935is.pdf |
